Combining iPSCs and ‘omics to identify molecular convergence in neurodegenerative disorders
Dr. Ward received his B.S. from Kenyon College in 1999 and M.D. and Ph.D. degrees from Washington University in St. Louis in 2007. As a graduate student, he worked in Yi Rao’s lab and studied the regulation of cell migration during neurodevelopment. Following a neurology residency at the University of California in San Francisco, he sub-specialised in behaviuoral neurology and completed a postdoctoral fellowship in Li Gan’s lab studying basic mechanisms of frontotemporal dementia. As a fellow he received an American Brain Foundation CRTF award and a NIH K08 career development award. In 2015 he joined the NINDS as an Assistant Clinical Investigator. His research focuses on identifying intersecting mechanisms of neurodegenerative diseases, with an ultimate goal of developing targeted, disease-modifying therapies for affected patients.
Date: 3 February 2020, 16:00 (Monday, 3rd week, Hilary 2020)
Venue: Sherrington Building, off Parks Road OX1 3PT
Venue Details: Small Lecture Theatre, second floor
Speaker: Dr Michael Ward (National Institute of Neurological Disorders & Stroke (NINDS))
Organising department: Department of Physiology, Anatomy and Genetics (DPAG)
Organiser: Professor Richard Wade-Martins (Professor of Molecular Neuroscience, University of Oxford)
Organiser contact email address: opdc.administrator@dpag.ox.ac.uk
Host: Professor Richard Wade-Martins (Professor of Molecular Neuroscience, University of Oxford)
Part of: OPDC Seminar Series (DPAG)
Topics:
Booking required?: Not required
Audience: Public
Editor: Lorraine Dyson